Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Venous Thrombosis × abelacimab × Clear all

Phase

Status

Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Pulmonary Embolism 1

Interventions

Enoxaparin 3 Dalteparin 3 Tinzaparin 2 Heparin, Low-Molecular-Weight 2 reviparin 1 certoparin 1 bemiparin 1 apixaban 1 acarboxyprothrombin 1 abelacimab 1 Warfarin 1 Phenprocoumon 1 Nadroparin 1 MAA868 1 Intermittent Pneumatic Compression Devices 1 Fondaparinux 1 Acenocoumarol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05171049 2026-02-23

ASTER

Anthos Therapeutics, Inc.

Phase 3 Terminated

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡